Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.

Although this did not reach statistical significance due to the limitation in mouse numbers feasible in this type of experiment, the data support the results obtained with Ifnar1 −/− mice, suggesting that IFN-I activity during pneumococcal infection controls transition of pneumococci from the lung into the bloodstream.

also in 111,027 other papers